David Moskowitz has been appointed chief financial officer at Unigene Laboratories, Inc. In this newly created position, Mr. Moskowitz will serve as a member of the company’s executive leadership team and lead the strategic direction of the company’s financial and capital markets activities. Mr. Moskowitz spent the past 13 years as an equity research analyst covering large-cap pharmaceutical, specialty pharmaceutical, biotechnology, and generic drug companies. Most recently, Mr. Moskowitz serve...